Early vs Late Phase Trials in Immuno-Oncology
Early vs Late Phase Trials in Immuno-Oncology Comparing Early and Late Phase Trials in Immuno-Oncology Introduction to Immuno-Oncology Clinical Development Immuno-oncology (I-O) has transformed cancer treatment, introducing therapies that harness the immune system to recognize and destroy tumor cells. The clinical development of I-O agents follows the traditional phase-based pathway—Phase I (early), Phase II, Phase…